Zoetis ZTS Poultry — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zoetis's poultry — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zoetis's poultry — revenue?
- Zoetis (ZTS) reported poultry — revenue of $118M in Q1 2026.
- How has Zoetis's poultry — revenue changed year-over-year?
- Zoetis's poultry — revenue increased by 11.3% year-over-year, from $106M to $118M.
- What is the long-term trend for Zoetis's poultry — revenue?
- Over 4 years (2021 to 2025), Zoetis's poultry — revenue has grown at a -3.9% compound annual growth rate (CAGR), from $507M to $432M.
- What does poultry — revenue mean?
- This metric represents the total net sales generated from the sale of health products, including vaccines, parasiticides, and anti-infectives, specifically tailored for the poultry production market. It reflects the company's exposure to the commercial poultry industry and the demand for preventative and therapeutic animal health solutions within that sector. Changes in this revenue stream are driven by global poultry production volumes, disease outbreaks, and the adoption of the company's proprietary health technologies.